• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 14, 2024

    3/14/24 5:52:13 AM ET
    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Multi-Sector Companies
    Miscellaneous
    Computer Software: Prepackaged Software
    Technology
    Get the next $ACTG alert in real time by email

    Companies Reporting Before The Bell

    • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

    • ImmunoPrecise Antibodies (NASDAQ:IPA) is likely to report quarterly loss at $0.07 per share on revenue of $4.50 million.

    • G-III Apparel Group (NASDAQ:GIII) is projected to report quarterly earnings at $0.67 per share on revenue of $817.48 million.

    • Dick's Sporting Goods (NYSE:DKS) is estimated to report quarterly earnings at $3.35 per share on revenue of $3.80 billion.

    • Protalix BioTherapeutics (AMEX:PLX) is likely to report quarterly loss at $0.03 per share on revenue of $5.80 million.

    • Hello Gr (NASDAQ:MOMO) is likely to report quarterly earnings at $0.34 per share on revenue of $405.61 million.

    • Weibo (NASDAQ:WB) is expected to report quarterly earnings at $0.49 per share on revenue of $455.09 million.

    • Futu Hldgs (NASDAQ:FUTU) is projected to report quarterly earnings at $0.96 per share on revenue of $331.79 million.

    • Akebia Therapeutics (NASDAQ:AKBA) is expected to report quarterly loss at $0.04 per share on revenue of $55.39 million.

    • Kandi Technologies Gr (NASDAQ:KNDI) is projected to report earnings for its fourth quarter.

    • Benson Hill (NYSE:BHIL) is estimated to report quarterly loss at $0.17 per share on revenue of $87.30 million.

    • KE Holdings (NYSE:BEKE) is likely to report quarterly earnings at $0.18 per share on revenue of $2.63 billion.

    • Dollar Gen (NYSE:DG) is expected to report quarterly earnings at $1.75 per share on revenue of $9.78 billion.

    • Hudson Glb (NASDAQ:HSON) is estimated to report quarterly earnings at $0.20 per share on revenue of $38.02 million.

    • InfuSystems Holdings (AMEX:INFU) is expected to report quarterly earnings at $0.00 per share on revenue of $30.00 million.

    • HF Foods Group (NASDAQ:HFFG) is likely to report earnings for its fourth quarter.

    • Burford Capital (NYSE:BUR) is estimated to report earnings for its Fiscal Year 2023.

    • Ucloudlink Group (NASDAQ:UCL) is expected to report quarterly earnings at $0.05 per share on revenue of $23.60 million.

    • Xunlei (NASDAQ:XNET) is likely to report earnings for its fourth quarter.

    • Build-A-Bear Workshop (NYSE:BBW) is projected to report quarterly earnings at $1.32 per share on revenue of $150.45 million.

    • Global X Guru Index ETF (NYSE:GURU) is projected to report quarterly loss at $0.05 per share on revenue of $6.85 million.

    • Century Casinos (NASDAQ:CNTY) is expected to report quarterly loss at $0.36 per share on revenue of $142.31 million.

    • Katapult Holdings (NASDAQ:KPLT) is expected to report quarterly loss at $1.79 per share on revenue of $55.81 million.

    • UroGen Pharma (NASDAQ:URGN) is estimated to report quarterly loss at $0.68 per share on revenue of $22.57 million.

    • Agenus (NASDAQ:AGEN) is projected to report quarterly loss at $0.05 per share on revenue of $47.05 million.

    • RumbleON (NASDAQ:RMBL) is estimated to report quarterly loss at $0.51 per share on revenue of $339.48 million.

    • Alarum Technologies (NASDAQ:ALAR) is expected to report quarterly earnings at $0.25 per share on revenue of $7.00 million.

    • Autolus Therapeutics (NASDAQ:AUTL) is estimated to report quarterly loss at $0.25 per share on revenue of $360 thousand.

    • United Homes Gr (NASDAQ:UHG) is projected to report earnings for its first quarter.

    • BK Technologies (AMEX:BKTI) is likely to report earnings for its fourth quarter.

    • Solo Brands (NYSE:DTC) is expected to report quarterly earnings at $0.17 per share on revenue of $166.15 million.

    • Mondee Hldgs (NASDAQ:MOND) is likely to report quarterly loss at $0.12 per share on revenue of $55.00 million.

    • GoHealth (NASDAQ:GOCO) is likely to report quarterly earnings at $2.72 per share on revenue of $363.88 million.

    • SecureWorks (NASDAQ:SCWX) is estimated to report quarterly loss at $0.03 per share on revenue of $87.18 million.

    • Aveanna Healthcare Hldgs (NASDAQ:AVAH) is projected to report quarterly loss at $0.02 per share on revenue of $467.40 million.

    • PSQ Holdings (NYSE:PSQH) is expected to report quarterly loss at $0.47 per share on revenue of $2.47 million.

    • Canadian Solar (NASDAQ:CSIQ) is expected to report quarterly earnings at $0.00 per share on revenue of $1.69 billion.

    • CION Invt (NYSE:CION) is expected to report quarterly earnings at $0.41 per share on revenue of $58.33 million.

    Companies Reporting After The Bell

    • Blend Labs (NYSE:BLND) is expected to report quarterly loss at $0.09 per share on revenue of $36.93 million.

    • Montauk Renewables (NASDAQ:MNTK) is estimated to report quarterly earnings at $0.07 per share on revenue of $56.87 million.

    • Getty Images Holdings (NYSE:GETY) is estimated to report quarterly earnings at $0.01 per share on revenue of $216.46 million.

    • Ulta Beauty (NASDAQ:ULTA) is likely to report quarterly earnings at $7.53 per share on revenue of $3.53 billion.

    • Skillz (NYSE:SKLZ) is projected to report quarterly loss at $1.41 per share on revenue of $38.09 million.

    • Rigetti Computing (NASDAQ:RGTI) is expected to report quarterly loss at $0.13 per share on revenue of $3.22 million.

    • Smartsheet (NYSE:SMAR) is estimated to report quarterly earnings at $0.18 per share on revenue of $255.38 million.

    • Phreesia (NYSE:PHR) is expected to report quarterly loss at $0.26 per share on revenue of $93.53 million.

    • Despegar.com (NYSE:DESP) is projected to report quarterly earnings at $0.17 per share on revenue of $191.43 million.

    • Frequency Electronics (NASDAQ:FEIM) is projected to report earnings for its third quarter.

    • Pyxis Tankers (NASDAQ:PXS) is projected to report earnings for its fourth quarter.

    • American Vanguard (NYSE:AVD) is likely to report quarterly earnings at $0.27 per share on revenue of $172.90 million.

    • The One Group Hospitality (NASDAQ:STKS) is projected to report quarterly earnings at $0.15 per share on revenue of $98.04 million.

    • Urgently (NASDAQ:ULY) is likely to report earnings for its fourth quarter.

    • Vaxart (NASDAQ:VXRT) is likely to report quarterly loss at $0.14 per share on revenue of $1.25 million.

    • Evoke Pharma (NASDAQ:EVOK) is likely to report quarterly loss at $0.50 per share on revenue of $1.63 million.

    • Marchex (NASDAQ:MCHX) is expected to report quarterly earnings at $0.00 per share on revenue of $12.75 million.

    • Kopin (NASDAQ:KOPN) is projected to report quarterly loss at $0.02 per share on revenue of $9.03 million.

    • Eastman Kodak (NYSE:KODK) is projected to report earnings for its fourth quarter.

    • Zumiez (NASDAQ:ZUMZ) is projected to report quarterly earnings at $0.26 per share on revenue of $275.87 million.

    • Tilly's (NYSE:TLYS) is projected to report quarterly loss at $0.22 per share on revenue of $171.65 million.

    • CytoSorbents (NASDAQ:CTSO) is projected to report quarterly loss at $0.14 per share on revenue of $9.28 million.

    • Energy Transfer (NYSE:ET) is projected to report quarterly earnings at $0.22 per share on revenue of $125.84 million.

    • Allogene Therapeutics (NASDAQ:ALLO) is projected to report quarterly loss at $0.45 per share on revenue of $20 thousand.

    • Adecoagro (NYSE:AGRO) is expected to report earnings for its fourth quarter.

    • Redwire (NYSE:RDW) is expected to report quarterly loss at $0.12 per share on revenue of $59.72 million.

    • Fathom Holdings (NASDAQ:FTHM) is estimated to report quarterly loss at $0.32 per share on revenue of $80.97 million.

    • Brilliant Earth Group (NASDAQ:BRLT) is estimated to report quarterly earnings at $0.01 per share on revenue of $124.61 million.

    • Karat Packaging (NASDAQ:KRT) is expected to report quarterly earnings at $0.41 per share on revenue of $95.48 million.

    • Mobile Infrastructure (AMEX:BEEP) is estimated to report earnings for its fourth quarter.

    • Babcock & Wilcox (NYSE:BW) is likely to report quarterly loss at $0.03 per share on revenue of $256.27 million.

    • Cardlytics (NASDAQ:CDLX) is projected to report quarterly earnings at $0.12 per share on revenue of $89.55 million.

    • Eton Pharmaceuticals (NASDAQ:ETON) is expected to report quarterly loss at $0.04 per share on revenue of $7.70 million.

    • EverCommerce (NASDAQ:EVCM) is expected to report quarterly earnings at $0.13 per share on revenue of $172.41 million.

    • Co-Diagnostics (NASDAQ:CODX) is expected to report quarterly loss at $0.20 per share on revenue of $3.62 million.

    • Acacia Research (NASDAQ:ACTG) is likely to report quarterly earnings at $0.07 per share on revenue of $8.00 million.

    • Alta Equipment Group (NYSE:ALTG) is estimated to report quarterly loss at $0.05 per share on revenue of $483.69 million.

    • Wheaton Precious Metals (NYSE:WPM) is expected to report quarterly earnings at $0.33 per share on revenue of $291.55 million.

    • Spruce Power Holding (NYSE:SPRU) is likely to report earnings for its fourth quarter.

    • aTyr Pharma (NASDAQ:LIFE) is estimated to report quarterly loss at $0.24 per share on revenue of $50 thousand.

    • Clipper Realty (NYSE:CLPR) is projected to report earnings for its fourth quarter.

    • Adobe (NASDAQ:ADBE) is likely to report quarterly earnings at $4.38 per share on revenue of $5.14 billion.

    • Heritage Glb (NASDAQ:HGBL) is expected to report quarterly earnings at $0.07 per share on revenue of $15.35 million.

    • NuScale Power (NYSE:SMR) is projected to report quarterly loss at $0.14 per share on revenue of $8.94 million.

    • Altus Power (NYSE:AMPS) is expected to report quarterly loss at $0.01 per share on revenue of $43.93 million.

    • Molecular Partners (NASDAQ:MOLN) is likely to report earnings for its Fiscal Year 2023.

    • FutureFuel (NYSE:FF) is likely to report earnings for its fourth quarter.

    • Harte-Hanks (NASDAQ:HHS) is expected to report quarterly earnings at $0.12 per share on revenue of $47.00 million.

    • Blink Charging (NASDAQ:BLNK) is likely to report quarterly loss at $0.31 per share on revenue of $35.64 million.

    • PagerDuty (NYSE:PD) is projected to report quarterly earnings at $0.15 per share on revenue of $110.40 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACTG
    $ADBE
    $AGEN
    $AGRO

    CompanyDatePrice TargetRatingAnalyst
    NuScale Power Corporation
    $SMR
    2/27/2026$21.00Market Perform → Outperform
    Northland Capital
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$33.00Buy
    Goldman
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$18.00Outperform
    Robert W. Baird
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$21.00Mkt Outperform
    Citizens
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$20.00Overweight
    Barclays
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$23.00Buy
    Deutsche Bank
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$13.00Overweight
    Analyst
    Ethos Technologies Inc.
    $LIFE
    2/23/2026$15.00Buy
    Citigroup
    More analyst ratings

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Botha Roelof bought $4,949,975 worth of shares (260,525 units at $19.00), converted options into 12,000,124 shares and returned 12,000,124 shares to the company (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    2/2/26 6:36:37 PM ET
    $LIFE
    Specialty Insurers
    Finance

    Director Wheeler William J bought $4,949,975 worth of shares (260,525 units at $19.00), increasing direct ownership by 2,481% to 271,025 units (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    1/30/26 8:49:26 PM ET
    $LIFE
    Specialty Insurers
    Finance

    Director Mullin Mark W. bought $99,997 worth of shares (5,263 units at $19.00), increasing direct ownership by 43% to 17,451 units (SEC Form 4)

    4 - Ethos Technologies Inc. (0001788451) (Issuer)

    1/30/26 8:48:09 PM ET
    $LIFE
    Specialty Insurers
    Finance

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Robinson James A. Jr. converted options into 2,000 units of ordinary shares, increasing direct ownership by 100% to 4,000 units (SEC Form 4)

    4 - UroGen Pharma Ltd. (0001668243) (Issuer)

    2/27/26 4:44:12 PM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Adlich Steve claimed ownership of 55,000 shares (SEC Form 3)

    3 - Redwire Corp (0001819810) (Issuer)

    2/27/26 4:44:03 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    SEC Form 4 filed by Eastman Kodak Company Common New

    4 - EASTMAN KODAK CO (0000031235) (Issuer)

    2/26/26 9:15:33 PM ET
    $KODK
    Industrial Machinery/Components
    Consumer Discretionary

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VAFSEO issued to AKEBIA THERAPEUTICS INC

    Submission status for AKEBIA THERAPEUTICS INC's drug VAFSEO (ORIG-1) with active ingredient VADADUSTAT has changed to 'Approval' on 03/27/2024. Application Category: NDA, Application Number: 215192, Application Classification: Type 1 - New Molecular Entity

    3/28/24 10:46:38 AM ET
    $AKBA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    SEC Filings

    View All

    SEC Form 10-K filed by Redwire Corporation

    10-K - Redwire Corp (0001819810) (Filer)

    2/27/26 5:15:43 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    Eastman Kodak Company Common New filed SEC Form 8-K: Leadership Update

    8-K - EASTMAN KODAK CO (0000031235) (Filer)

    2/27/26 5:00:27 PM ET
    $KODK
    Industrial Machinery/Components
    Consumer Discretionary

    InfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InfuSystem Holdings, Inc (0001337013) (Filer)

    2/27/26 4:54:04 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Mach 2 and Beyond: Aerospace Enters Its Biggest Spending Cycle

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity Insider News Commentary -- Congress approved $839 billion in Pentagon funding for fiscal 2026, $8 billion more than the Department of Defense requested, with billions earmarked for space, missile defense, and advanced aerospace systems[1]. The Pentagon's $152 billion reconciliation spending plan allocates $2.2 billion specifically to accelerate hypersonic defense systems and $5.6 billion for space-based interceptors[2]. Companies positioned across aerospace testing, defense technology, and space infrastructure include Starfighters Space (NYSE-A: FJET), Kratos Defense (NASDAQ:KTOS), V2X (NYSE:VVX), Redwire (NYS

    2/27/26 11:24:00 AM ET
    $FJET
    $KTOS
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials

    ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC

    • EORTC Recurrence Score Analysis from the Pivotal ENVISION Trial to be Presented at the 2026 American Society of Clinical Oncology's Genitourinary Cancers Symposium (ASCO-GU 2026) PRINCETON, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative, non-surgical therapies for urothelial and specialty cancers, today announced new post-hoc analyses from the Phase 3 ENVISION trial showing that ZUSDURI™ (mitomycin) for intravesical solution (formerly known as UGN-102) achieved durable complete response (CR) rates across European Organization for Research and Treatment of Cancer (EORTC) recurrence score g

    2/27/26 8:30:00 AM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NuScale Power upgraded by Northland Capital with a new price target

    Northland Capital upgraded NuScale Power from Market Perform to Outperform and set a new price target of $21.00

    2/27/26 8:22:27 AM ET
    $SMR
    Metal Fabrications
    Industrials

    Goldman initiated coverage on Ethos Technologies with a new price target

    Goldman initiated coverage of Ethos Technologies with a rating of Buy and set a new price target of $33.00

    2/23/26 8:37:19 AM ET
    $LIFE
    Specialty Insurers
    Finance

    Robert W. Baird initiated coverage on Ethos Technologies with a new price target

    Robert W. Baird initiated coverage of Ethos Technologies with a rating of Outperform and set a new price target of $18.00

    2/23/26 8:37:19 AM ET
    $LIFE
    Specialty Insurers
    Finance

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Financials

    Live finance-specific insights

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Babcock & Wilcox Sets Fourth Quarter 2025 Conference Call and Webcast for Monday, March 16, 2026 at 5 p.m. ET

    Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the "Company") will host a conference call and webcast on Monday, March 16, 2026 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's fourth quarter and full year 2025 results. The Company expects to issue a news release detailing the results prior to the March 16 conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 470-1428; the dial-in number for participants in Canada is (833) 950-0062; the di

    2/26/26 5:07:00 PM ET
    $BW
    Building Products
    Industrials

    Montauk Renewables Schedules Full Year 2025 Conference Call for Thursday, March 12, 2026, at 8:30 a.m. ET

    PITTSBURGH, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas ("RNG"), will host a conference call and webcast on Thursday, March 12, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the full year ended December 31, 2025. The Company will issue a press release reporting the financial results after the close of regular stock market trading hours on the day prior to the conference call and webcast. Full Year 2025 Conference Call and Webcast Details  Date:Thursday, March 12, 2026Time:8:30 a.m. ETPartici

    2/26/26 4:30:00 PM ET
    $MNTK
    Natural Gas Distribution
    Utilities

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Trading: Significant Buy at Marchex Inc. on Jun 5

    On June 5, 2024, Miller Edwin A made a significant insider purchase at Marchex Inc., acquiring $272,000 worth of Class B Common Stock, amounting to 200,000 units at a price of $1.36 per unit. This transaction represented a substantial increase in direct ownership by 1,107%, bringing Edwin A's total holdings to 218,066 units as reported in the SEC Form 4. Examining this purchase in the context of previous insider activities reveals interesting patterns worth noting. Horowitz Russell C was granted 15,000 units of Class B Common Stock on October 2, 2023, resulting in a 2% increase in direct ownership to 991,918 units. Similarly, Wisehart Manuel W was granted 15,000 units on the same date, incr

    6/10/24 1:01:02 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Leadership Updates

    Live Leadership Updates

    View All

    Fathom Realty Appoints Stephanie Verderose as Vice President of Growth

    CARY, N.C., Feb. 17, 2026 /PRNewswire/ -- Fathom Realty, a subsidiary of Fathom Holdings Inc. (NASDAQ:FTHM) (the "Company"), a national, technology-driven real estate services platform integrating residential brokerage, mortgage, title, and SaaS offerings, today announced the appointment of Stephanie Verderose as Vice President of Growth. In this newly created role, Verderose will report directly to Lori Muller, President of Fathom Realty, and will lead initiatives focused on agent production, agent attraction and retention, and community development. Verderose is a respected re

    2/17/26 8:30:00 AM ET
    $FTHM
    Real Estate
    Finance

    Build-A-Bear Workshop, Inc. Names James A. Goldman to Board of Directors

    Build-A-Bear Workshop, Inc. (NYSE:BBW) is pleased to announce the appointment of James A. Goldman to its Board of Directors, effective immediately. "After conducting an extensive search, we are pleased to welcome Mr. Goldman to our Board of Directors. We are confident that Mr. Goldman's extensive experience in leading successful global retail and branded consumer companies will enable him to make an immediate contribution as we look to accelerate our long-term strategic initiatives and continue to create value for our shareholders," said Craig Leavitt, Non-Executive Chairman of the Board. James A. Goldman has served on the Board of Directors of Domino's Pizza, Inc., a global restaurant

    2/10/26 4:05:00 PM ET
    $BBW
    Recreational Games/Products/Toys
    Consumer Discretionary

    Fathom Realty Appoints Lori Muller as President

    Veteran Real Estate Leader to Drive Continued Growth and Agent Success CARY, N.C., Feb. 10, 2026 /PRNewswire/ -- Fathom Realty, a subsidiary of Fathom Holdings Inc. (NASDAQ:FTHM) (the "Company"), a national, technology-driven real estate services platform integrating residential brokerage, mortgage, title, and SaaS offerings, today announced the appointment of Lori Muller as President of Fathom Realty, effective February 9, 2026. Muller succeeds Samantha Giuggio, who will be stepping down from her roles as President of Fathom Realty and Chief Operating Officer of Fathom Holdings.

    2/10/26 8:30:00 AM ET
    $FTHM
    Real Estate
    Finance

    $ACTG
    $ADBE
    $AGEN
    $AGRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by United Homes Group Inc

    SC 13G - United Homes Group, Inc. (0001830188) (Subject)

    12/17/24 5:44:48 PM ET
    $UHG
    Homebuilding
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by United Homes Group Inc

    SC 13D/A - United Homes Group, Inc. (0001830188) (Subject)

    12/13/24 6:24:20 PM ET
    $UHG
    Homebuilding
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Skillz Inc.

    SC 13D/A - Skillz Inc. (0001801661) (Subject)

    12/12/24 4:01:36 PM ET
    $SKLZ
    EDP Services
    Technology